Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)
Clinical trial NCT02057887 · UNKNOWN
Trial details
- NCT number
- NCT02057887
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-08-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.